Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures
NCT04849858Phase 3Terminated
- Sponsor
- University of California, Irvine
- Start
- May 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of liposomal bupivacaine in postoperative pain (3 arms), sponsored by University of California, Irvine. Primary endpoint: Post-operative opioid consumption. Started May 2019; status: terminated.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04849858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04849858.